Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, today reported financial results ...
12h
Exagen (XGN): Revenue Growth Outlook Challenges Bearish Sentiment as Valuation Remains Undemanding
Exagen (XGN) remains unprofitable, but the company has managed to cut its annual losses by 4.7% over the last five years. While forecasts call for continued red ink over the next three years, revenue ...
DuBois, PA / / August 6, 2025 / Highroad Enterprises Key Takeaways StemWave Shockwave Therapy achieves an 85% success rate for sustained improvement in chronic pain conditions without surgery. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback